Product photography not yet available.
AMI RETA
R530,00 – R1 730,00Price range: R530,00 through R1 730,00
Retatrutide in 15mg, 30mg and 60mg options, each listed as a vial, pen or cartridge. For laboratory research only.
Out of stock
- Pens and cartridges are made on order.
- Peptides are received, stored and shipped cold.
For laboratory research use only. This product is not a medicine and is not for human or veterinary use. It is not intended to diagnose, treat, cure or prevent any disease.
Retatrutide is offered in 15mg, 30mg and 60mg options across vial, pen and cartridge formats. It has its own product listing and should not be confused with Tirzepatide or Semaglutide.
A published phase 2 trial describes retatrutide as an agonist at GIP, GLP-1 and glucagon receptors. The trial concerns its investigational material and study conditions, not the Aminos product. No clinical outcome or product approval is claimed here.
Check the compound name as well as the strength when comparing these listings. If your laboratory needs a particular formulation or identity specification, confirm it before placing an order.
Retatrutide, also called LY3437943, is a single peptide agonist of GIP, GLP-1 and glucagon receptors. This triple-receptor profile separates it from tirzepatide and semaglutide.
Identity and context
The three receptor targets describe pharmacology, not three mixed ingredients. A complete retatrutide structure must account for its chemical modifications. This entry deliberately omits a standard-residue-only sequence and calculated molecular mass that would imply an incomplete structure was sufficient.
Reference classification
Modified peptide. The linked catalogue product is Retatrutide. This reference does not independently authenticate the material supplied.
| Form | Vial | Pen | Cartridge |
|---|---|
| Available strengths | 15mg | 30mg | 60mg |
| Storage | Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide. |
Analytical specification
Request lot-specific identity evidence that names LY3437943 or retatrutide and describes the full modified molecule. A generic incretin label is not enough to distinguish the three receptor profiles.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Related products
AMI CJC-DAC
CJC 1295 with DAC at 5mg, in vial, pen or cartridge format. Check the DAC designation when comparing it with the without-DAC listing.
AMI SEMAX
Semax in 5mg or 10mg, with vial, pen and cartridge choices. A separate Semax reference is available for background reading.
AMI TIRZ
Choose Tirzepatide in 15mg, 30mg or 60mg, with vial, pen and cartridge options. Compare the listed amount and format before ordering.
Reviews
There are no reviews yet.